When Trauma Gets Under the Skin: C-PTSD, Chronic Stress, and Inflammation
How prolonged adversity may shape the stress-response system, influence immune function, and affect mental and physical well-being.
Trauma does not always end when the traumatic experience is over. For people who have experienced prolonged or repeated interpersonal trauma, particularly during childhood, the effects may extend beyond memories, emotions, and relationships. They may also be reflected in the body's stress-response systems and, potentially, its regulation of inflammation.
Complex post-traumatic stress disorder (C-PTSD) offers an important framework for understanding these lasting effects. In addition to the core symptoms of PTSD, C-PTSD can involve persistent difficulties with emotional regulation, a negative sense of self, and disturbances in relationships. These difficulties can affect how a person experiences safety, connection, and the world around them.
Emerging research suggests that chronic stress and early adversity may also be associated with changes in immune function. Although inflammation is not present in everyone with a trauma history, understanding this potential connection may help us develop a more comprehensive view of the relationship between psychological trauma, brain function, and physical health.
When the Stress Response Becomes Persistent
The human stress-response system is designed to help us respond to danger. When a threat is detected, the brain and body coordinate a series of physiological changes that prepare us to act. The hypothalamic-pituitary-adrenal (HPA) axis helps regulate the release of cortisol, while the autonomic nervous system influences heart rate, breathing, vigilance, and other bodily functions.
Under ordinary circumstances, these responses fluctuate with changing demands and eventually move toward baseline when the threat has passed.
Repeated exposure to danger, however, can create a very different developmental environment. A child who grows up amid abuse, neglect, chronic conflict, or unpredictable caregiving may have limited opportunities to experience consistent safety. Over time, anticipating danger can become an important organizing principle of daily life.
These adaptations are not evidence that the person is defective. They may reflect attempts to survive in an environment where vigilance and rapid responses to threat were necessary.
The longer-term consequences are complex. Research on early adversity suggests that childhood maltreatment is associated with differences in stress physiology and immune markers in adulthood. A systematic review by Coelho and colleagues (2014), for example, found associations between childhood maltreatment and several inflammatory indicators, with C-reactive protein among the more consistent findings. The studies varied in their methods, however, and the results do not establish that childhood trauma inevitably produces chronic inflammation.
The central question is whether, for some individuals, the biological adaptations that help manage prolonged threat may also contribute to difficulties regulating stress and immune activity later in life.
From Chronic Stress to Inflammatory Signaling
Inflammation is an essential part of the immune system. It helps the body respond to infection, injury, and other challenges. The problem is not inflammation itself, but the possibility that inflammatory activity may become prolonged, poorly regulated, or activated in contexts where it offers little benefit.
Stress and immune function communicate through several interconnected pathways. The HPA axis, autonomic nervous system, immune cells, and inflammatory signaling molecules all participate in this relationship. Under chronic stress, these systems may become dysregulated. In some circumstances, immune cells may also become less responsive to the regulatory effects of glucocorticoids, including cortisol.
Inflammatory cytokines—signaling proteins such as interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor necrosis factor alpha (TNF-α)—are among the molecules being investigated in relation to chronic stress and mental health.
A 2023 systematic review and meta-analysis by Kuring and colleagues examined 64 studies involving people with clinically significant depression, anxiety, or PTSD. The researchers found evidence of inflammatory changes associated with these conditions, while also noting that the nature of the inflammatory response appeared to differ across diagnostic groups. The evidence was stronger for some associations than others.
Importantly, this research concerns depression, anxiety, and PTSD broadly; it does not establish a distinct inflammatory profile for C-PTSD.
That distinction matters. It would be premature to conclude that all people with C-PTSD have chronic inflammation or that a particular inflammatory marker can identify the disorder. Instead, the evidence supports further investigation into whether immune dysregulation is one of several biological pathways through which prolonged adversity may affect health.
How Inflammation May Influence the Brain
The relationship between inflammation and the brain is an active area of research. Peripheral immune signaling can communicate with the central nervous system through multiple pathways, including neural signaling, interactions at the blood-brain barrier, and signaling molecules that influence brain function. These processes are complex, and the degree to which they occur varies across circumstances.
Within the brain, microglia and other glial cells participate in immune surveillance, synaptic regulation, and the maintenance of neural environments. Inflammatory signaling can influence these processes, as well as neurotransmitter metabolism, stress responsivity, and neural plasticity.
A review by Hassamal (2023) describes several proposed mechanisms linking chronic stress, immune dysregulation, neuroinflammatory processes, and depression. These include changes in HPA-axis regulation, inflammatory signaling, and pathways involved in neurotransmission and neural circuit function.
This research is relevant to trauma clinicians because symptoms such as fatigue, reduced motivation, sleep disturbance, and difficulty concentrating can occur in people experiencing both psychological distress and physical illness. Inflammatory processes may contribute to some of these symptoms in certain individuals, but they are not the only possible explanation.
It is also essential to distinguish peripheral inflammation from neuroinflammation. An elevated blood marker, such as C-reactive protein, does not by itself demonstrate inflammation within the brain. Nor does it establish that inflammation is causing a person's psychological symptoms.
The more defensible conclusion is that immune activity and brain function can influence one another, and that this interaction may help explain some—but certainly not all—of the variation in mental health outcomes following chronic adversity.
A Bidirectional Relationship
One of the most important implications of this research is that the relationship between stress, inflammation, and mental health may be bidirectional.
Chronic stress may influence immune regulation. Inflammatory signaling, in turn, may affect aspects of mood, energy, sleep, and cognition. These effects can potentially make it more difficult to manage daily stressors, creating additional challenges for someone already struggling with trauma-related symptoms.
This should not be understood as a single, inevitable biological cycle. The relationships are influenced by many factors, including genetics, physical health, sleep, medication, nutrition, socioeconomic conditions, ongoing adversity, and access to supportive relationships.
People respond differently to similar experiences of trauma. Some develop persistent psychiatric symptoms; others demonstrate substantial resilience. Even among people with C-PTSD, biological patterns are unlikely to be uniform.
Recognizing this variability helps us avoid a reductionist view of trauma in which one molecule or pathway is expected to explain a complex human experience.
What Does This Mean for Trauma Treatment?
If prolonged adversity can affect multiple interacting systems, then a comprehensive approach to recovery should consider more than symptoms alone.
Psychotherapy remains central to the treatment of trauma-related difficulties. Depending on the individual, treatment may involve processing traumatic memories, strengthening emotional regulation, developing a more coherent sense of self, and improving the capacity to experience safety and connection. The therapeutic relationship can provide an important context in which new relational experiences become possible.
A mind-body perspective also encourages attention to sleep, physical activity, medical concerns, and other aspects of health that influence overall functioning. These are not substitutes for trauma-focused treatment; they are potential components of a broader approach to well-being.
There is growing interest in whether psychological and behavioral interventions can influence inflammatory markers, but findings are not yet sufficient to conclude that a particular trauma therapy reliably reduces inflammation or that reducing inflammation is the mechanism through which therapy works.
Likewise, inflammation should not be assumed to be the cause of persistent symptoms simply because a person has experienced childhood trauma. Decisions about medical testing or treatment for suspected inflammatory conditions should be guided by appropriate medical assessment rather than trauma history alone.
The clinical implication is not that every person with C-PTSD needs an inflammatory workup. It is that mental and physical health are interconnected, and that persistent symptoms deserve a thoughtful assessment that considers both psychological and medical factors.
Beyond the Legacy of Threat
Perhaps the most meaningful shift is to understand trauma-related symptoms not simply as signs of dysfunction, but as part of a broader pattern of adaptation to adversity.
For a person who grew up in an unpredictable environment, vigilance may once have served a protective purpose. Emotional detachment may have helped make overwhelming experiences more manageable. Difficulty trusting others may have developed in relationships where trust was repeatedly violated.
These adaptations can persist long after the original circumstances have changed. Recovery may involve gradually developing new ways of responding to the present—ways that allow for greater flexibility, connection, and a more reliable experience of safety.
Neuroscience can help us investigate the biological dimensions of this process, including the relationship between chronic stress and immune function. But it cannot, on its own, capture the full meaning of trauma or the many pathways through which people recover.
The emerging research on inflammation invites us to expand our understanding of C-PTSD without reducing it to biology. Prolonged adversity may leave traces across psychological, physiological, and relational systems. Those effects are neither universal nor necessarily permanent, and their mechanisms remain an active area of study.
A comprehensive model of healing therefore makes room for the whole person: brain and body, history and present experience, individual biology and the relationships in which recovery takes place.
Understanding how trauma may become biologically embedded is one part of that work. Understanding how people develop new experiences of safety, agency, and connection is another.
References
Coelho, R., Viola, T. W., Walss-Bass, C., Brietzke, E., & Grassi-Oliveira, R. (2014). Childhood maltreatment and inflammatory markers: A systematic review. Acta Psychiatrica Scandinavica, 129(3), 180–192. https://doi.org/10.1111/acps.12217
Hassamal, S. (2023). Chronic stress, neuroinflammation, and depression: An overview of pathophysiological mechanisms and emerging anti-inflammatories. Frontiers in Psychiatry, 14, 1130989. https://doi.org/10.3389/fpsyt.2023.1130989
Kuring, J. K., Mathias, J. L., Ward, L., & Tachas, G. (2023). Inflammatory markers in persons with clinically-significant depression, anxiety or PTSD: A systematic review and meta-analysis. Journal of Psychiatric Research, 168, 279–292. https://doi.org/10.1016/j.jpsychires.2023.10.009
